EP3631454
Meðhöndlun á LAG-3-jákvæðum æxlum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
30.5.2018EP published:
13.9.2023EP application number:
18735009.5
EP translation filed:
30.10.2023Grant published:
15.12.2023EPO information:
European Patent Register
Max expiry date:
29.5.2038Expiry date:
29.5.2026Next due date:
31.5.2026
Title in English:
TREATMENT OF LAG-3 POSITIVE TUMORSLanguage of the patent:
English
Timeline
Today
30.5.2018EP application
13.9.2023EP Publication
30.10.2023Translation submitted
15.12.2023Registration published
29.5.2026Expires
Owner
Name:
Bristol-Myers Squibb CompanyAddress:
Route 206 and Province Line Road, Princeton, NJ 08543, US
Inventor
Name:
NOVOTNY, James Jr.Address:
Milford, New Jersey 08848, US
Name:
LONBERG, NilsAddress:
Woodside, California 94062, US
Name:
HEDVAT, CyrusAddress:
New York, New York 10075, US
Name:
CLYNES, RaphaelAddress:
West Nyack, New York 10994, US
Name:
LOCKE, DarrenAddress:
Bordentown, New Jersey 08505-1714, US
Name:
COGSWELL, John P.Address:
Yardley, Pennsylvania 19067, US
Name:
JACKSON, JeffreyAddress:
Princeton, New Jersey 08543, US
Name:
HARBISON, ChristopherAddress:
Hamilton, New Jersey 08619, US
Name:
EDWARDS, RobinAddress:
Princeton, New Jersey 08543, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201762512648 PDate:
30.5.2017Country:
US
Number:
201762513813 PDate:
1.6.2017Country:
US
Number:
201762555176 PDate:
7.9.2017Country:
US
Number:
201762582178 PDate:
6.11.2017Country:
US
Classification
Categories:
G01N 33/574, A61K 39/395, A61K 39/00, A61P 35/00, C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 9.4.2024
Expires: 29.5.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 9.5.2025
Expires: 29.5.2026
Payer: Árnason Faktor ehf.